HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Imatinib treatment of therapy resistant generalized deep morphea.

AuthorsCarmen María Alcántara-Reifs, Gloria María Garnacho-Saucedo, Rafael Salido-Vallejo, Sofía de la Corte-Sánchez, Antonio Vélez García-Nieto
JournalDermatologic therapy (Dermatol Ther) 2015 Sep-Oct Vol. 28 Issue 5 Pg. 271-3 ISSN: 1529-8019 [Electronic] United States
PMID26032018 (Publication Type: Case Reports, Letter)
Chemical References
  • Protein Kinase Inhibitors
  • Imatinib Mesylate
Topics
  • Female
  • Humans
  • Imatinib Mesylate (therapeutic use)
  • Middle Aged
  • Protein Kinase Inhibitors (therapeutic use)
  • Scleroderma, Localized (drug therapy, pathology)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: